Free CME from PeerView


Hematology CME

Nirav Shah, MD, MS
Credits: 0.5 CME / MOC
Medical Learning Institute, Inc.
Visualizing Progress With BTK Inhibitors: An Animated Journey Through the Mechanisms of Covalent and Noncovalent Options
Nirav Shah, MD, MS
November 19, 2021
Credits: 0.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Changing the Game for Patients With Prurigo Nodularis: Best Practices to Achieve Treatment Goals and Improve Quality of Life
October 28, 2021
Credits: 0.5 CME
Medical Learning Institute, Inc.
On the Cusp of a New Targeted Treatment Era in ALS: Exploring the Emerging Therapeutic Landscape
October 21, 2021
Credits: 0.5 CME
Medical Learning Institute, Inc.
Integrating the Latest Evidence Into Practice: Expert Insights on Targeted Biologic Therapy for Pediatric and Adult Patients With Moderate to Severe Atopic Dermatitis
October 19, 2021
Todd Mosher
Credits: 0.5 CME
Medical Learning Institute, Inc.
Advancing Treatment of von Willebrand Disease: A Visual Exploration on Personalizing Care With Current and Emerging Management Strategies
October 14, 2021
Credits: 0.50 CME
Penn State College of Medicine
Improving the Recognition and Effective Management of Axial Spondyloarthritis: Practical Guidance for the Primary Care Provider
Philip J. Mease, MD, MACR
October 12, 2021
Credits: 1.00 CME / MOC / NCPD
Medical Learning Institute, Inc.
Interprofessional Perspectives on Safety Management With Targeted Therapy for B-Cell Malignancies
Anthony R. Mato, MD, MSCE
October 4, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Breaking Therapeutic Barriers in RRMM: Team-Based Solutions for Integrating Novel Antibody Platforms and Improving Myeloma Care
Sagar Lonial, MD, FACP
October 1, 2021
Credits: 0.25 CME
Johns Hopkins University School of Medicine
Advances in the Management of IBD: Expert Insight on What’s New and What’s Next
Aline Charabaty, MD, AGAF, FACG
September 29, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Raising the Bar for Patient Outcomes With Transcription Inhibition and Other New Options in the Treatment Arsenal for SCLC: Rationale, Mechanisms of Action, Latest Data, and Practicalities of Clinical Use in Oncology Practice
Jared Weiss, MD
September 29, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Taking Action in Advanced Biliary Cancers: Expert Insights on Integrating Newly Available and Innovative Therapeutics to Deliver Precision-Based Care
Milind Javle, MD
September 28, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Across the Age Spectrum: Expert Insights on Emerging Uses of Targeted Therapy for the Treatment of Uncontrolled Moderate to Severe Asthma
Ian Pavord, FMedSci
September 27, 2021
Credits: 0.25 NCPD
Medical Learning Institute, Inc.
Ushering in a New Wave of Progress in Advanced Hepatobiliary Cancers: Expert Perspectives on Incorporating New Evidence and Innovative Therapeutics to Deliver Optimal, Patient-Centered Care
Jackie Weatherly, PA-C
September 27, 2021
Credits: 0.75 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Collaborative Strategies for Managing VOD/SOS: Interprofessional Insights on Advances in Diagnosis, Severity Grading, and Treatment
Kenneth R. Cooke, MD
September 24, 2021
Credits: 0.50 CME / MOC / CC
Medical Learning Institute, Inc.
Secondary AML Through the Microscope: A Pathology-Informed Guide to Modern Diagnostic and Treatment Principles
Sanam Loghavi, MD
September 20, 2021
Credits: 0.50 CME / NCPD
Medical Learning Institute, Inc.
Test Your Knowledge of New and Emerging Therapies for Moderate to Severe Atopic Dermatitis: Latest Evidence and Clinical Potential
Jonathan I. Silverberg, MD, PhD, MPH
September 17, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Taking Aim at the TYK2 Pathway in Psoriasis: Addressing Unmet Treatment and Patient Needs With an Innovative Therapeutic Approach
April W. Armstrong, MD, MPH
September 17, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD
September 14, 2021
Credits: 1.25 CME / MOC
Medical Learning Institute, Inc.
Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics
Srdan Verstovsek, MD, PhD
September 10, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Seizing the Day With BTK Inhibitors in CLL: Evidence-Informed Therapy Selection, Safety, and Sequential Care
Nicole Lamanna, MD
September 9, 2021
Credits: 1 CME
Medical Learning Institute, Inc.
The Next Building Block for B-Cell Cancer Care: Exploring Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL
September 8, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Visualizing the Present and Future of CLL: How Innovative Therapies and State-of-the-Art Combinations Are Transforming Patient Care
Ian W. Flinn, MD, PhD
September 7, 2021
Credits: 1 CME / MOC / CC / NCPD
PVI, PeerView Institute for Medical Education
Maximizing the Potential of Immunotherapy in Multimodal Management of Unresectable Stage III NSCLC: Collaboration Is Crucial, Patient Selection Is Paramount, Close Monitoring Is Critical
September 1, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes
Ruben A. Mesa, MD, FACP
August 25, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Redrawing the Algorithm in Gastric and GEJ Cancers: Treatment Planning and Sequencing in the Era of Immunotherapy
Manish A. Shah, MD, FASCO
August 23, 2021
Credits: 1.00 NCPD
Medical Learning Institute, Inc.
Taking the Fight to AML: Oncology Nurse Perspectives, Principles, and Practice in an Era of Innovative Therapies
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
August 18, 2021
Alok A. Khorana, MD, FACP, FASCO / Robert D. McBane, II, MD
Credits: 0.75 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Reducing the Global Burden of Cancer-Associated VTE: Applying Guideline-Concordant, Evidence-Based Care and Shared Decision-Making Strategies to Improve Patient Outcomes
Alok A. Khorana, MD, FACP, FASCO / Robert D. McBane, II, MD
August 10, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
The Contemporary Use of GLP-1 RAs to Individualize Therapy in T2DM: Candid Conversations on Glycemic and Nonglycemic Effects
James R. Gavin III, MD, PhD
July 27, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Determining Which Patients Will Benefit From GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM
Vanita R. Aroda, MD
July 16, 2021
Credits: 1.00 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer: Latest Data Informing Best Practices for Multimodal Management of Stage I-III NSCLC
Jamie E. Chaft, MD
July 12, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView